Engineering the Microbiome: From Gut Health to Systemic Therapies
- What does it actually mean to “engineer” the microbiome, and how close are we?
- How does a disrupted gut microbiome drive disease far beyond the intestine, and can we reverse it?
- What will it take to turn microbiome science into medicines patients can actually receive?
Sara Dauber – Session Moderator
Vice President
JP Morgan Life Sciences
Walter Colsman
CoFounder
Expora
Melanie Rutkowski
Associate Professor, Microbiology, Immunology, and Cancer Biology
University of Virginia
Jason Papin
Professor, BME
University of Virginia